About Washington Biotechnology
Washington Biotechnology was a Healthcare company based in Seattle (United States) founded in 1988 by Sean ONeill. A contract research organization providing in vivo services to evaluate the efficacy of small molecules and biologics, including vaccines. It operates on a B2B model. Its chief executive, as recorded, is Sean ONeill. The company is recorded as dissolved. Its focus areas include Biotechnology, Contract Research and In Vivo Services. Its competitors include PsychoGenics, InVivo Biosystems and Noble Life Sciences; 2 of its 3 listed competitors have raised funding.
Company details
Washington Biotechnology operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, contract research, and in vivo services. A contract research organization providing in vivo services to evaluate the efficacy of small molecules and biologics, including vaccines. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Seattle, United States
- Founders Sean ONeill
- SectorsHealthcare
- Website washingtonbiotech.com
People of Washington Biotechnology
1 people are tracked at Washington Biotechnology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sean ONeill | Founder, CEO | Leadership |
Complete people profiles for Washington Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Washington Biotechnology
Washington Biotechnology has 3 listed competitors in our database, 2 of them funded. They include PsychoGenics, InVivo Biosystems and Noble Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| psychogenics.com | 1999 | Tarrytown, United States | 124 | Preclinical CRO services for CNS and orphan disorders are offered. | ||
| invivobiosystems.com | 2019 | United States | $8.16M | Animal models are supplied for in-vivo analytical services. | ||
| noblelifesci.com | 2010 | Woodbine, United States | $335,000 | Preclinical contract research organization offering standard GLP and non-GLP services |
Detailed competitors of Washington Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Washington Biotechnology
Websites that share an audience with Washington Biotechnology (washingtonbiotech.com).
Websites whose visitors overlap most with Washington Biotechnology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| prevalere.com | 100% | View details | |||
| meliordiscovery.com | 98% | 3.6K | #3,218,060 | View details | |
| pharmatek.com | 92% | View details | |||
| tklresearch.com | 80% | 9.5K | #4,608,578 | View details | |
| emmes.com | 77% | 57.4K | #665,925 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Washington Biotechnology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Washington Biotechnology (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Washington Biotechnology
Washington Biotechnology was founded in 1988.
Washington Biotechnology is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Sean ONeill is the CEO of Washington Biotechnology, as recorded in our data. They have also founded this company.
Washington Biotechnology operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, contract research, and in vivo services. A contract research organization providing in vivo services to evaluate the efficacy of small molecules and biologics, including vaccines. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Washington Biotechnology's top competitors include PsychoGenics, InVivo Biosystems and Noble Life Sciences.